Office of Continuing Professional Development
Thyroid Cancer & Parathyroid Disease Update 2021 - Virtual Meeting
Friday, December 10, 2021
The Jefferson Thyroid Cancer and Parathyroid Disease Update 2021: Updates in Diagnosis and Treatment offers participants a unique opportunity to virtually witness experts deliberate and debate how they would manage a patient's thyroid cancer and parathyroid diseases. This active learning format features critical deliberations regarding patient cases, clinical findings, differential diagnoses, and management plan options. Participants will examine cases from multiple perspectives, and gain an in-depth understanding of how experienced healthcare providers approach difficult patient care decisions. Keynote Lectures from leading practitioners provide evidence for care decisions discussed in panels which will increase confidence in diagnostic and treatment decision making for participants.
Presented by Thomas Jefferson University and Louisiana State University Health Sciences Center New Orleans
4th Annual Jefferson Sialendoscopy Course
Wednesday, February 3, 2021
This course will introduce the equipment and techniques needed to incorporate this minimally invasive procedure into practice.
Lively, interactive case-based discussions from expert faculty and intensive analysis of real-life patient interviews and surgical footage highlight this annual program.
Participants will examine the advantages of sialendoscopy and identify patients for whom this minimally invasive procedure would be most appropriate. Specific strategies to incorporate sialendoscopy and hybrid techniques into practice will be identified.
Jefferson Thyroid and Parathyroid Conference 2019: Updates in Diagnosis and Treatment
Friday, November 8, 2019
Jefferson Alumni Hall - Center City Campus of Thomas Jefferson University
1020 Locust Street
Philadelphia, PA 19107
This continuing education conference provides an active learning environment allowing participants to engage in critical deliberations and debates with nationally renowned experts in the field of thyroid cancer and parathyroid disease.
This innovative course will be of interest to all specialists working in the field of thyroid disease: general and endocrine surgeons, otolaryngologists, endocrinologists, oncologists, pathologists, family physicians, medical imagers, physician assistants, nurses and trainees.
4th Annual Thomas Jefferson University - Seoul National University Endoscopic Skull Base Symposium
Saturday-Sunday, April 9-10, 2016
Dorrance H. Hamilton Building - 5th Floor
1001 Locust Street
Philadelphia, PA 19107
The Division of Endocrinology, Diabetes and Metabolic Diseases provides comprehensive care for patients with Type I and Type II diabetes mellitus, obesity and thyroid nodules and goiters. Expert evaluation and management of other hormonal and glandular disorders involving the thyroid, pituitary, parathyroid and adrenal glands, as well as osteoporosis, other bone disorders and calcium metabolism and disorders of cholesterol and triglyceride metabolism.
- make transformational discoveries of the cellular and molecular biology of the malignant process and the individual's and society's response to it
- effectively translate the latest research discoveries and clinical trials to provide the highest quality of care to all patients including those of diverse ethnic and racial populations
- provide expert and humanitarian care to cancer patients, their families, and those at risk
The Department of Otolaryngology - Head and Neck Surgery at Jefferson University Hospital is the regional leader in minimally invasive thyroid and parathyroid surgery. The department serves a large and varied patient community, including children, and features specialized centers and programs dedicated to hearing and balance disorders, taste and smell disorders, reconstructive and facial plastic surgery, and, uniquely, the care of the professional performing or voice-over artist. For our multidisciplinary approach to head and neck cancer, we collaborate closely with Jefferson University Hospital's Kimmel Cancer Center and Center for Integrative Medicine
The Kimmel Cancer Center (KCC) was founded in 1991 and is one of a select group of cancer centers in the nation designated by the National Cancer Institute. Today, the KCC has approximately 150 members that include physicians and scientists dedicated to discovery and development of novel approaches for cancer treatment. The mission of the Kimmel Cancer Center, a National Cancer Institute-designated cancer center, is to: